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ABSTRACT
The objective of the study was to evaluate the cardioprotective activity of flax lignan concentrate (FLC) in isoprenalin (ISO) induced 
cardiotoxicity in rats. Male Wistar rats (200–230 g) were divided into three groups. Group I: control, Group II: isoprenalin, Group III: 
FLC (500 mg/kg, p.o.) orally for 8 days and in group II and III isoprenalin 5.25 mg/kg, s.c. on day 9 and 8.5 mg/kg on day 10. On day 10 
estimation of marker enzymes in serum and haemodynamic parameters were recorded. Animals were sacrificed, histology of heart 
was performed. Isoprenalin showed cardiotoxicity, manifested by increased levels of marker enzymes and increased heart rate. FLC 
treatment reversed these biochemical changes significantly compared with ISO group. The cardiotoxic effect of isoprenalin was 
less in FLC pretreated animals, which was confirmed in histopathological alterations. Haemodynamic, biochemical alteration and 
histopathological results suggest a cardioprotective protective effect of FLC in isoprenalin induced cardiotoxicity. 
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myocardial infarction due to generation of highly cyto-
toxic free radicals through its auto-oxidation (Rona et al., 
1959). Higher levels of catecholamines deplete the energy 
reserve of cardiac muscle cells, leading to complex bio-
chemical and structural changes that cause irreversible 
cellular damage and ultimately necrosis (Rona, 1985).
Isoprenalin-induced myocardial necrosis in animals 
[either by subcutaneous (s.c.) or intraperitoneal injection] 
was first reported by Rona et al. (1959). The biochemical 
and histological changes occurring after administration 
of this agent in rats have been well documented. The phar-
macologic effect of isoprenalin is believed to be associated 
with its β-adrenergic effect, which increases heart rate, 
decreases blood pressure and diminishes the oxygen sup-
ply to the myocardium. Within 6 min of intraperitoneal 
isoprenalin injection, histological changes occur, includ-
ing myofilament fragmentation (Kung & Blau, 1978).
Linum usitatissimum (Linn.), commonly known as 
flaxseed or linseed belongs to the family Linaceae. The 
flax plant is not a new crop and is native to West Asia 
and the Mediterranean. As the source of linen fiber, 
flax has been cultivated since at least 5000 BC (Oomah, 
Introduction
Ischaemic heart disease is a leading cause of morbid-
ity and mortality worldwide. The pathophysiology of 
cellular damage due to ischaemia is complex. Reactive 
oxygen species are known to play a major role and are a 
target for therapeutic interventions (Li & Jackson, 2002). 
I t  i s  w e ll  r e c o g n i z e d  t h a t  i s c h a e m i c  t i s s u e  g e n e r a t e s  
oxygen-derived free radicals and other reactive species 
which bring about oxidative damage of membrane lipids, 
proteins and carbohydrates leading to qualitative and 
quantitative alterations of the myocardium (Burton et 
al., 1984). Isoprenalin (ISO), a synthetic catecholamine 
and β-adrenergic agonist is documented to produce 
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2001). Traditionally, flaxseed has been grown for its oil. 
Flaxseed has been playing a major role in the field of diet 
and disease research due to its potential health benefits 
associated with high content of α-linolenic acid (ALA) 
(57%), which is an essential omega-3-fatty acid and also 
because of a major lignan, namely secoisolariciresinol 
diglucoside (SDG). Flaxseed is an oilseed that contains 
about 38–45% oil. ALA content in flax oil is 55–60% and 
lignan content in flaxseed is up to 13 mg/g flaxseed (Hall 
et al., 2006). The lignan SDG is converted by bacteria 
in the colon of humans and other animals to enterodiol 
and enterolactone, referred to as mammalian lignans. 
These exhibit weak estrogenic activity as they can bind 
to estrogen receptors on cell membranes (Nesbitt et al., 
1999). The interest in ALA and lignans has opened oppor-
tunities. Flaxseed is also an good source of protein and 
dietary fibre, accounting for 20% and 28% of the flaxseed, 
respectively (Hall et al., 2006).
With better understanding of the process involved 
in the pathophysiology of myocardial infarction, it is 
possible to investigate the cardioprotective ingredient in 
food. Many dietary antioxidants and some non-nutrient 
based antioxidants from plants, such as sulphur contain-
ing compounds in garlic, phyto-oestrogens in soy, green 
tea, anthocyanins in red berries, lycopene in tomatoes, red 
and white wines from grape seeds are increasingly being 
recognized as potential health promoters in reducing the 
risk of cardiovascular disease and atherosclerosis (Ames et 
al., 1993). Flaxseed has gained much importance in recent 
times as ethnomedicine due to its wide pharmacological 
actions. Although its therapeutic potential, as antioxi-
dant, primarily as hydroxyl radical scavenger, anticancer, 
antidiabetic antiviral, bactericidal, anti-inflammatory, 
and antiatherosclerotic agent is known (Zanwar et al., 
2010; Rajesha et al., 2006; Chen et al., 2002; Prasad, 2000; 
Collins et al., 2003; Kinniry et al., 2006; Prasad, 1997), 
very few studies evaluating its cardioprotective potential 
are presently available (Penumathsa et al., 2008, 2007). 
The objective of the present investigation was to study 
the effect of flax lignan concentrate (FLC) extracted from 
seeds of Linum usitatissimum on isoprenalin induced 
cardiotoxicity in Wistar rats.
Materials and methods
Collection and authentication of plant
Authenticated seeds of Linum usitatissimum were 
obtained from Dr. P . B. Ghorpade, Principal, Scientist 
and Linseed Breeder, Punjabrao Deshmukh Krushi 
Vidyapeeth, College of Agriculture, Nagpur, India, 
Maharashtra State, India, and voucher specimen was 
deposited at the institute.
Drugs and chemicals
Isoprenalin (ISO) (Sigma Chemicals, St. Louis, USA) was 
procured for induction of myocardial necrosis. Absolute 
alcohol (Changshu Yangyuan Chemicals, China) was pur-
chased from respective vendors. n-Hexane, hydrochloric 
acid, sodium hydroxide and sodium chloride of analytical 
grade were purchased from Qualigene fine-chem. Ltd, 
Mumbai, India. Solvents (ethyl acetate, methanol, formic 
acid) and precoated silica gel plates of 0.2 mm. thickness 
(silica gel 60 F-254) used for the present study were pro-
cured from Merck Ltd. Mumbai, India.
Preparation of ﬂ  ax lignan concentrate (FLC)
Several methods have been reported for extraction of 
lignan (Charlet et al., 2002; Eliasson et al., 2003; Muir 
& Westcott, 2000; Meagher et al., 1999; Fritsche et al., 
2002). We prepared lignan extract by using these methods 
and analysed the SDG content. The highest SDG content 
could be extracted by the method of Eliasson et al. (2003). 
Briefly, the double cold pressed flaxseed cake/meal (200 g) 
was obtained from the Indian Council of Agricultural 
Research under National Agriculture Innovation Project, 
Omega-3-oil unit, Sangamner, Maharashtra, India. This 
seed cake was defatted by n-hexane in soxhlet appara-
tus to remove residual oil. The defatted cake was then 
hydrolysed with 1 M aqueous sodium hydroxide for 1 h at 
room temperature with intermittent shaking, followed by 
extraction with 50% ethanol. Then the filtrate was acidi-
fied to pH 3 using 1 M hydrochloric acid. The filtrate was 
dried on a tray dryer at 50 °C. The yield of FLC was 14.81% 
w/w. The powdered ethanolic extract was dissolved in 
distilled water to prepare different concentrations of FLC 
and used for chromatographic analysis and pharmaco-
logical studies.
Preparation of standard solutions and FLC 
for chromatographic analysis
Stock SDG standard solution (concentration 2  mg/ml) 
was prepared by dissolving 2 mg of pure SDG in 1 mL of 
double distilled water assembly (Labponko, Missoruri, 
USA). The working solution was prepared by further 
dilution in methanol to make final concentration as 2, 4, 
6, 8, 10, 12 and 14 μL of these were applied to a thin layer 
chromatography (TLC) plate, using an automatic TLC 
sampler (Linomat 5) for preparing six point calibration 
curves. FLC was dissolved in distilled water and further 
appropriate dilutions were made in methanol.
Chromatography
A Camag high-pressure thin-layer chromatography 
(HPTLC) system equipped with an automatic TLC sam-
pler (Linomat 5), TLC scanner 3, and integrated software 
Win-Cats version 4 was used for the analysis. HPTLC 
was performed on a precoated silica gel HPTLC 60F254 
(20  ×  10  cm) for the quantification of SDG in FLC. The 
samples and the standards were applied on the plate as 8 
mm wide bands. The linear ascending development was 
carried out in a camag twin trough chamber (20 × 20 cm), 
which was pre-saturated with 30 mL mobile phase with 
ethyl acetate: methanol: water: formic acid (7:1.5:1:0.5) 
for 15–20 min, at room temperature. The length of the 
chromatogram run was up to 80 mm. Subsequent to the 
development, the TLC plate was dried in a current of 
air and with a hair dryer. Quantitative evaluation of the 92
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plate was performed in the absorption reflection mode at 
282 nm using Win-Cats software by considering dilution 
factor of sample.
Research protocol approval
The experimental protocol was approved by the 
Institutional Animal Ethics Committee (IAEC) consti-
tuted in accordance with the rules and guidelines of the 
Committee for the Purpose of Control and Supervision on 
Experimental Animals (CPCSEA), India.
Experimental animals
Male Wistar rats weighing between 200 and 230  g and 
Swiss albino mice ( 1 8– 23  g) were purchased from the 
National Institute of Bioscience, Pune, India. The animals 
were housed at an ambient temperature of 25±2 °C, rela-
tive humidity 50±2% and light and dark cycle (12 h light/
dark). The animals had access to pellet diet (Chakan oil 
mills, Pune) and water ad libitum.
Acute oral toxicity study
Swiss albino mice of either sex were subjected to acute 
toxicity studies as per guideline (AOT No. 425) suggested 
by the Organization for Economic Co-operation and 
Development 2001. The mice were observed by hous-
ing them individually in polypropylene metabolic cages 
continuously for 2 h for behavioral, neurological and 
autonomic profiles and for any lethality during the fol-
lowing 48 h.
Selection of FLC dose
The study was carried out using three doses of FLC, i.e. 
125 mg/kg, 250 mg/kg and 500 mg/kg. The results of the 
lower two doses, i.e. 125  mg/kg and 250  mg/kg, are not 
presented as no significant activity was observed.
Experimental design and protocol
A total of 18 animals were randomly divided into three 
groups comprising of six animals per group.
Group I: control group, animals received distilled 
water as a vehicle for 8 days and normal saline (s.c.) on   
day 9 and 10.
Groups II: animals received ISO (5.25 mg/kg, s.c. on 
day 9 and 8.5 mg/kg on day 10 in normal saline) (Mali & 
Bodhankar, 2010).
Groups III: received FLC (500 mg/kg, p.o.) in distilled 
water for 8 days and then ISO (5.25 mg/kg, s.c.) on day 9 
and 8.5 mg/kg on day 10 in normal saline). 
Serum parameters
After 24 hr of the last dose of ISO, blood was collected 
from the retro-orbital plexus of each rat under mild 
ether anesthaesia (TKM Pharma, India) for determina-
tion of biochemical parameters. Serum was separated in 
cryocentrifuge (Eppendroff, India) at 4 ˚C at 6 000 rpm. 
for 15 min and lactate dehydrogenase (LDH), creatine 
phosphokinase-MB isoenzyme (CK-MB) and aspartate 
transaminase (AST) were measured by using standard 
kits according to the manufacturer’s instruction manual 
(Merck Specialities Pvt. Ltd. India) using an autoanalyser 
(Nihon Kohden, Japan). 
Haemodynamic parameters
After 24 hr of the last dose of ISO, the animals were 
anaesthetised by urethane (1.25  g/kg) intrapritoneally. 
The right carotid artery of each rat was cannulated for 
the measurement of heart rate (HR), blood pressure (BP) 
systolic blood pressure (SBP), diastolic blood pressure 
(DBP) and mean aterial blood pressure (MABP). The 
cannula was filled with heparinised saline and con-
nected to a pressure transducer. The haemodynamic 
parameters were recorded by eight-channel-power lab 
(AD Instruments, Australia) having LABCHART-6 
Pro software. The percentage decrease in BP, SBP, DBP, 
MABP was calculated by the formula: 
% = reading of treated group / reading of control group × 100
After recording of haemodynamic parameters, the 
animals were euthanised and the heart was removed and 
placed in 10% formalin solution. The organ specimens 
were subjected to dehydration with xylene ( one hour 
each) and alcohol of 70, 90 and 100% strength each for 
two hours. The infiltration and impregnation was carried 
out by treatment with paraffin wax twice for each time 
for one hour. Parrafin wax was used to prepare paraffin 
L molds. Specimens were cut into sections of 3–5  mm 
thickness and stained with haematoxylin and eosin (H 
& E). The sections were mounted by diestrene phthalate 
xylene (D.P.X.). The parameters of histopathology assess-
ment of heart sections were inflammation, necrosis and 
congestion. The grading system used for assessment 
of parameters was [– : absence of change; + : 0–30% 
area shows changes; + + : 30–60% area shows changes; 
+ + + : 60–100 area shows changes].
Statistical analysis
Data were expressed as the mean ± S.E.M. Statistical 
analysis was carried out by one-way ANOVA followed 
by post hoc Bonferroni test using graphpad prism 5.00 
for Windows, GraphPad Software, San Diego California 
USA, www.graphpad.com. The p-value was considered 
significant when p<0.05.
Results
Chromatography
With some modification in compositions of mobile phases 
used by Coran et al. (2004), we got better resolution of 
SDG. Peaks corresponding to SDG were recorded at Rf 
0.35 (Figure 1A). FLC, when subjected to HPTLC, showed 
the presence of SDG peaks at the same Rf (Figure 1B). 
The calibration curves were linear in the range of 200, 
400, 800, 1 600, 2 400, 3 200 ng for SDG (Figure 1C). Peak 
purity tests of SDG were also conducted by comparing 
UV visible spectra of SDG standard and sample track 93
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(Figure 1D). The SDG content in FLC was found to be 
40 mg/g, from calibration curve Y= –30.717+50.254×X, r= 
0.9998, Standard deviation (Sdv) =0.60 (Figure 1D).
Acute toxicity studies
In acute oral toxicity studies, no changes in the behaviour 
and autonomic profiles and no mortality were observed 
in treated and control groups of the mice up to the dose 
of 5 000 mg/kg.
Eﬀ  ect of FLC on serum parameters in rats after 
isoprenalin induced myocardial infarction 
The effects of FLC on serum marker enzymes LDH, 
CK-MB and AST are shown in Table 1. ISO-treated 
group of animals showed significant (p<0.01) increase 
in the activity of CK-MB compared to the control group. 
Treatments with FLC 500  mg/kg to ISO challenged 
animals significantly decreased the activities of CK-MB 
elevated by ISO (p<0.01). LDH was significantly higher in 
ISO treated rats compared to control group (p<0.001) and 
FLC at the dose of 500 mg/kg decreased LDH, though not 
to control value. Isoprenalin increased significantly AST 
in ISO treated group compared to control group (p<0.05). 
FLC 500 mg/kg was effective in reducing AST compared 
to ISO group.
Haemodynamic pattern
In the control-vehicle treated animals the recorded 
heart rate (HR) was 322.0±8.59. Isoprenalin significantly 
increased the heart rate (397.8±13.62) p<0.05 compared 
to of the control group. In FLC + ISO group the heart rate 
(364.1±27.83) did not increase significantly compared to 
control and was lesser than that of ISO group. The result 
thus indicated that FLC pretreatment for 8 days was 
effective in arresting isoprenalin-induced tachycardia 
(Table 2).
Eﬀ  ect of FLC and ISO on blood pressure
In the control animals treated with vehicle the recorded 
BP values were following: recorded BP 109±4.67 mmHg, 
systolic BP was 112.9±5.23  mmHg, diastolic BP was 
105.4±4.11  mmHg and the mean arterial BP was 
107.9±4.44  mmHg. The values obtained in the control 
animals treated with ISO were following: recorded BP was 
100.9±3.66 mmHg (8%), systolic BP was 104.9±3.41 mmHg 
(7%), diastlic BP was 95.7±4.54 mmHg (12.8%) and mean 
a r t e r i a l  B P  w a s  9 8 . 7 ± 3 . 9 6   m m H g  ( 8 . 5 % )  r e s p e c t i v e l y .  
FLC+ISO (500 mg/kg) decreased BP to 94.82±3.04 mmHg 
(p<0.05) (13.5%), systolic BP to 96.91±3.76 mmHg (p<0.05) 
(14%), diastolic BP to 91.90±2.96 mmHg (12.8%) and mean 
arterial BP to 93.57±2.93 mmHg (p<0.05) (13%) compared 
to ISO alone (Table 2).
Histopathology
Figure 2 illustrates the section of heart tissue in control 
rats (A), in rats that received ISO only (B) and in rat that 
received ISO+FLC (500 mg/kg) (C). The histopathology of 
the heart of the control group showed absence of inflam-
mation, necrosis and congestion (graded as −: absence of 
changes). Isoprenalin administration in the control group 
showed inflammation (++), necrosis (++) and congestion 
(+) which means that a 30–60% area of the rat heart was 
inflamed, necrosis occurred in a 30–60% area of heart and 
0–30% was congested. Inflammation and congestion in 
large areas of the heart confirmed cardiotoxicity in rats. 
On the other hand, inflammation, necrosis and congestion 
were observed in a smaller area of the heart (+, 0–30%) in 
FLC+ISO (500  mg/kg). The results of histopathological 
analysis thus indicated that the rat heart was partially 
protected by pre-treatment with FLC (500 mg/kg) against 
isoprenalin-induced cardiotoxicity.
Discussion
Heart failure is a serious clinical syndrome with progres-
sive myocardial dysfunction and a poor clinical outcome. 
Several studies have confirmed the role of inflamma-
tion and oxidative stress in progression of heart failure. 
Table 1. Effect of FLC on serum parameters in rats after isoprenalin-
induced myocardial infarction.
Control ISO FLC 500 mg/kg
CK-MB 1211± 338.7  2703±139.2 a 1286±301.9   b
LDH 2161±487.5 8153±576.6   c 5747±1354 
AST 194.2±33.61   338.5±34.34 d 271.2±31.56
Values are expressed as Mean ± SEM. Data was analyzed by One-way ANOVA 
followed by post hoc Bonferroni test. p<0.05 considered as significant. a = 
**p<0.01 compared to control group, b = **p<0.01 compared to ISO group, c 
= ***p<0.001 compared to control group, d = **p<0.05 compared to control 
group.
Table 2. Effect of isoprenalin on heart rate, blood pressure, diastolic 
pressure, systolic pressure and mean arterial blood pressure after 
10-day treatment with FLC.
Control ISO FLC 500 mg/kg
HR 322.0±8.595 397.8±13.62 a  364.1±27.83
BP 109.7±4.673 100.9±3.666 94.82±3.048 b
SBP 112.9±5.238 104.9±3.416 96.91±3.764 b
DBP 105.4±4.117 95.7±4.548 91.90±2.967
MABP 107.9±4.445 98.7±3.968 93.57±2.933 b
Values are expressed as Mean  ±  SEM. Data were analyzed by one-way 
ANOVA followed by post hoc Bonferroni test using GraphPad Prism 5.00 for 
Windows, GraphPad Software, San Diego California USA. The p value was 
considered significant when p<0.05. a = *p<0.05 compared to control group, 
b = *p<0.05 compared to ISO group.94
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Isoproterenol-induced myocardial necrosis is a well estab-
lished model of myocardial infarction (MI) in rats (Rona, 
1985). It has been established that catecholamines in large 
doses produce myocardial necrosis. Previously we have 
reported in vitro antioxidant activity of flaxseed (Zanwar 
et al., 2010) and in vivo antioxidant activity was reported 
by Rajesha et al. (2006). Therefore, the present study eval-
uated the role of FLC in fighting isoprenalin-associated 
damage in the myocardium of MI rats. Along with various 
proposed mechanisms of isoprenalin-induced MI, gen-
eration of free radicals is one of the important causative 
factors (Singal et al., 1983).
In the present investigation, the observed changes 
in haemodynamic parameters after administration of 
isoprenalin in control rats were comparable to earlier 
reported ones (Mali & Bodhankar, 2010). Isoprenalin 
injection on the 9th and 10th day significantly increased 
the HR compared to that of the control group. Increased 
myocardial oxygen demand leads to ischaemic necrosis 
of the myocardium in rats. ISO+FLC produced a non-
significant decrease in HR compared to that of ISO. 
After isoprenalin treatment, 24-h blood pressure mea-
surement showed a non-significant decrease in MABP. 
FLC pretreatment attenuated the hypotensive effect of 
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Figure 1. Chromatography. A: HPTLC densitogram of SDG standard; B: HPTLC densitogram of FLC; C: Calibration curves in linear in the 
range of 200, 400, 800, 1 600, 2 400, 3 200 ng for SDG standard; D: UV spectra of standard SDG and SDG present in the FLC samples obtained 
by HPTLC spot scanning from 200 to 400 nm.95
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isoprenalin and tachycardia. Isoprenalin produces rela-
tive ischaemia or hypoxia due to myocardial hyperactiv-
ity and coronary hypotension (Balazs & Ferranst, 1978) 
and induces myocardial ischaemia due to cytosolic Ca2+ 
overload (Rona, 1985). Additionally, isoprenalin causes 
myocardial ischaemia due to excessive production of free 
radicals resulting from oxidative metabolism of catechol-
amines (Singal et al., 1983).
Apart from haemodynamic parameters, several diag-
nostic marker enzymes like CK-MB isoenzyme and LDH 
present in the myocardium are used as predictor of patho-
logical changes in the heart. These enzymes are released 
into the extracellular fluid during myocardial injury 
(Balazs & Ferranst, 1978). CK-MB is a standard marker 
of myocardial injury or death. CK-MB leaks out from 
the myocardium due to disintegration of the contractile 
apparatus and increased sarcoplasmic permeability (Mair 
et al., 1994). In the isoprenalin group the significant 
increase in CK-MB indicated myocyte injury. A lesser 
increase in CK-MB after isoprenalin in the FLC-treated 
group indicated cardioprotective activity of FLC. So our 
experimental data showed lowered activities of these 
enzymes in FLC-treated rats than in isoprenalin-treated 
rats, indicating protection against necrotic damage 
Figure 2. Photomicrographs of histopathological changes of rat heart at 20× and 40×.
A (20×) (–, absence of change), A1 (40×) Control group,
B (20×) (+ +, 30–60% necrosis), B1 (40×) ISO (8.5 mg/kg, s. c.) group,
C (20×) (+, 0–30% necrosis), C1 (40×) FLC (500 mg/kg, p.o.) + ISO (8.5 mg/kg s. c.)
U – Unremarkable, NM – Necrotic myocardial cells, I – Infl  ammatory cells.96
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of the myocardial membrane. The lower LDH level in 
FLC-treated group, although is not significant, following 
isoprenalin insult, further supports the protective effect. 
Increase in the serum level of AST in the isoprenalin 
alone group compared to the control group indicates 
myocardial necrosis. FLC-treated rats had a lower level of 
AST, indicating cardioprotection. The activity of FLC also 
seems to preserve the structural and functional integrity 
of the myocardial membrane, as evident from the reduc-
tion in the elevated levels of these serum marker enzymes 
in rats pretreated with FLC when compared to the ISO 
alone group, establishing thus the cardioprotective effect 
of FLC.
Isoprenalin, a potent synthetic catecholamine, 
when administered to animals in high doses produces 
‘‘infarct-like’’ lesions in the heart, which are similar to 
those found in acute myocardial infarction and sud-
den death in man (Baroldi, 1974). The pathogenesis of 
AMI has not yet been understood fully, despite studies 
on dose and rate of ISO-induced cardiotoxicity. ISO 
administration of 5.25 mg/kg on day 9 and 8.5 mg/kg on 
day 10 induced moderate lesions in the myocardium and 
significantly altered various biochemical parameters. The 
cardioprotective activity of FLC was evaluated against 
these doses. Isoprenalin produces relative ischaemia or 
hypoxia due to myocardial hyperactivity and coronary 
hypotension, and induces myocardial ischaemia due to 
cytosolic Ca2+ overload. Additionally, isoprenalin causes 
myocardial ischaemia due to excessive production of 
free radicals resulting from oxidative metabolism of 
catecholamines (Rona, 1985). Although cardiotoxicity 
could occur primarily via adrenoceptor activation, there 
is increasing evidence that it may also occur through 
oxidative mechanisms. Dhalla et al. (2000) reported that 
excess catecholamines affect Ca2+-transport mechanisms 
primarily via oxidation reactions involving free-radical-
mediated damage and antioxidants may be beneficial 
in stress-induced heart disease. A considerable amount 
of biochemical, physiological and pharmacological data 
support the link between free radicals and cardiovascular 
tissue injury, associated mainly with increase in vascular 
ROS production. Our earlier studies were indicative of the 
antioxidant property of FLC as a scavenger of different 
free radicals, including anion superoxide (O2
−), hydroxyl 
radicals (OH•) and hydroxyl observed in several biological 
models (Zanwar et al., 2010). FLC might reduce or pre-
vent excessive production of free radicals, exhibiting its 
cardioprotective effect. Histopathological finding of the 
FLC (500  mg/kg, p.o.) pre-treated myocardium showed 
reduction in necrosis and inflammation seen with iso-
proterenol treatment. FLC (500  mg/kg) treated normal 
rats showed only 0–30% cardiac necrotic architecture. 
These data further confirmed the cardioprotective action 
of oral administration of FLC. FLC, which contains SDG 
lignan, is biphenolic and an effective scavenger of reactive 
oxygen species and can inhibit lipid peroxidation through 
chelation of transition metal ions or their chain-breaking 
antioxidant activity. The observed effects might be due to 
the antioxidant effect of SDG present in FLC, redirecting 
the haemodynamic, biochemical, and histopathological 
changes towards normal values.
Conclusion
It is concluded that 10-day administration of FLC reduced 
isoprenalin-induced tachycardia. Protection from car-
diotoxic effect of isoprenalin in FLC-pretreated animals 
was established by haemodynamic, biochemical, and 
histopathological results. The antioxidant effect appears 
to contribute to the cardioprotective effect of flax lignan 
concentrate in isoprenalin-induced cardiotoxicity.
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